McMurdo 2005.
Methods |
|
|
Participants | Inclusion criteria
Exclusion criteria
|
|
Interventions | Treatment group
Control group
Duration of treatment: 6 months |
|
Outcomes |
|
|
Notes |
|
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Stratified by gender and computer generated |
Allocation concealment (selection bias) | Low risk | Held by pharmacy, sealed numbered enveloped |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Blinding stated |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Blinding stated |
Incomplete outcome data (attrition bias) All outcomes | Low risk | All patients analysed and reported; Losses to follow‐up/withdrawals: 115 |
Selective reporting (reporting bias) | Low risk | Appropriate clinical outcomes |
Other bias | Low risk | No other bias apparent, well reported study Source of funding: Chief Scientist Office at the Scottish Executive Department of Health. The cranberry juice and matching placebo were supplied by Ocean Spray Cranberries, Inc. |